Group B Streptococcus antigens
US8226953B2 · kind B2 · utility
2Cited by
15References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 28, 2010 |
| Grant date | Jul 24, 2012 |
| Priority date | — |
| Expiry date | Dec 28, 2030 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K39/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Group B streptococcus (GBS) proteins and polynucleotides encoding them are disclosed. Said proteins are antigenic and therefore useful vaccine components for the prophylaxis or therapy of streptococcus infection in animals. Also disclosed are recombinant methods of producing the protein antigens as well as diagnostic assays for detecting streptococcus bacterial infection.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.